Eric D. Achtyes, MD, MS, DFAPA
Eric D. Achtyes, MD, MS, DFAPA
Eric D. Achtyes, MD, MS, DFAPA graduated from Calvin College and then earned a master’s degree in chemistry from the University of Washington in Seattle. He completed medical school at the University of Michigan, his internship at the Michigan State University Kalamazoo Center for Medical Studies (MSU-KCMS) and his adult psychiatry residency training at the Massachusetts General Hospital/McLean/Harvard program where he served as chief resident on the addictions inpatient unit at McLean Hospital. Following residency, he was an attending psychiatrist treating patients and conducting research at Pine Rest Christian Mental Health services for 15 years, served as the Director of the Division of Psychiatry & Behavioral Medicine for the Michigan State University College of Human Medicine for 11 years and was the Medical Director for Network180 for 9 years. He is currently Professor and Chair of Psychiatry at the Western Michigan University Homer Stryker M.D. School of Medicine (WMed) where he teaches and mentors medical students and psychiatric residents.
Dr. Achtyes has been an investigator on more than sixty clinical trials in schizophrenia and depression, including both industry and federally funded research projects from NIMH, NIDA, NIA, NICHD, NIAAA and CMS, and has authored more than 100 publications in peer-reviewed journals including in the American Journal of Human Genetics, BMJ, JAMA, JAMA Psychiatry, Lancet Psychiatry, Molecular Psychiatry and Nature Medicine. He is currently an Associate Editor in the Schizophrenia section for the journal Frontiers in Psychiatry. He has served as the President of the Michigan Psychiatric Society and is a Distinguished Fellow of the American Psychiatric Association. He has been elected to membership in the AOA and Sigma Xi honor societies, and in 2022 he was named ‘Physician/Psychiatrist of the Year’ by NAMI Michigan.
Dr. Achtyes has been an investigator on more than sixty clinical trials in schizophrenia and depression, including both industry and federally funded research projects from NIMH, NIDA, NIA, NICHD, NIAAA and CMS, and has authored more than 100 publications in peer-reviewed journals including in the American Journal of Human Genetics, BMJ, JAMA, JAMA Psychiatry, Lancet Psychiatry, Molecular Psychiatry and Nature Medicine. He is currently an Associate Editor in the Schizophrenia section for the journal Frontiers in Psychiatry. He has served as the President of the Michigan Psychiatric Society and is a Distinguished Fellow of the American Psychiatric Association. He has been elected to membership in the AOA and Sigma Xi honor societies, and in 2022 he was named ‘Physician/Psychiatrist of the Year’ by NAMI Michigan.